Sohini Das, Aneeka Chatterjee

Stories by Sohini Das, Aneeka Chatterjee

How Kalki's Bujji Was Born

How Kalki's Bujji Was Born

Rediff.com   1 Jul 2024

'Fun stuff does, indeed, happen on X.'

Quality Lapses Shut Down Drug Makers

Quality Lapses Shut Down Drug Makers

Rediff.com   28 Jun 2024

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.

'Residential and hospitality are best-performing sectors'

'Residential and hospitality are best-performing sectors'

Rediff.com   25 Jun 2024

'The overall market cycle is very positive.'

Bharat Biotech finally names ICMR as co-owner in Covaxin patent filings

Bharat Biotech finally names ICMR as co-owner in Covaxin patent filings

Rediff.com   25 Jun 2024

After reports claimed that filings in patent offices in India, the US, and Europe did not mention ICMR or its scientists, but only BBIL and its scientists, the Hyderabad-based biotechnology (biotech) company clarified that in the "rush" to develop vaccines and file appropriate patents, BBIL had missed adding ICMR's name in the original filings.

Millennials Spark Luxury Homes Demand

Millennials Spark Luxury Homes Demand

Rediff.com   20 Jun 2024

High-end apartments, penthouses, and bungalows boasting amenities like swimming pools, expansive driveways, and premium interiors are becoming highly sought after.

Cleaner Fuels Driving One-Fifth Of PVs Sold In India

Cleaner Fuels Driving One-Fifth Of PVs Sold In India

Rediff.com   18 Jun 2024

Auto manufacturers have focused on launching CNG variants of their popular models to meet consumer demand for vehicles with lower running costs.

United Breweries sees fizz in premium beer segment

United Breweries sees fizz in premium beer segment

Rediff.com   10 Jun 2024

Bengaluru-based United Breweries (UBL), makers of Kingfisher beer, is eying strong growth in the premium beer segment, driven by changing consumer preferences towards premiumisation. "Across categories, premiumisation is taking place as people are looking for better choices and beer is no different. "People are upgrading to better beer and newer brands. We have a good offering of premium brands - Kingfisher's premium variants are Ultra and Ultra Max," Vikram Bahl, chief marketing officer (CMO), UBL, said in an interview.

In home and office, India's real estate market is charting a course for growth

In home and office, India's real estate market is charting a course for growth

Rediff.com   8 Jun 2024

India's real estate market is poised for growth across categories - residential, commercial, and rental. Currently valued at Rs 24 trillion, or about $300 billion, it is projected to surge to $1.3 trillion by 2034, and then grow further to $5.17 trillion by 2047, indicates a report by the Confederation of Real Estate Developers Associations of India (Credai).

'Second-gen promoters more open to selling out'

'Second-gen promoters more open to selling out'

Rediff.com   6 Jun 2024

'There is not any negative connotation associated with it.'

'We will continue to invest in commercial properties'

'We will continue to invest in commercial properties'

Rediff.com   3 Jun 2024

'A positive momentum in the southern market as far as leasing, absorption, and rentals are concerned.'

'Depending on the product, the pricing pressure will always be there'

'Depending on the product, the pricing pressure will always be there'

Rediff.com   3 Jun 2024

'That is a significant milestone for us and something we aspired for.'

'Expect formulations biz to outpace API biz'

'Expect formulations biz to outpace API biz'

Rediff.com   2 Jun 2024

'API prices are dragging down margins and impacting our competitive ability.'

New-Gen COVID Jabs Coming Soon...

New-Gen COVID Jabs Coming Soon...

Rediff.com   28 May 2024

India currently does not have any XBB 1.5 variant-based vaccines available.

Recharge Zones To Cool Clothing: Indian Companies' Summer Strategies

Recharge Zones To Cool Clothing: Indian Companies' Summer Strategies

Rediff.com   23 May 2024

Several firms are stepping up to help their workforce cope with soaring temperatures

Should Govt Continue Covid Vax Drive?

Should Govt Continue Covid Vax Drive?

Rediff.com   20 May 2024

India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities.

M&M shifts to high gear with Rs 37K cr investments

M&M shifts to high gear with Rs 37K cr investments

Rediff.com   17 May 2024

Automotive (auto) major Mahindra & Mahindra (M&M), which is readying to launch nine sport utility vehicles (internal combustion engine/ICE), seven Born Electric Vehicles (BEVs), and seven light commercial vehicles by 2030, has outlined an investment of Rs 27,000 crore in its auto business between 2024-25 (FY25) and 2026-27 (FY27). Over the next three years, the company will deploy Rs 37,000 crore, including its auto business, farm business (Rs 5,000 crore), and service business (Rs 5,000 crore).

Breweries stir up barrels with mercury rising

Breweries stir up barrels with mercury rising

Rediff.com   6 May 2024

For all the livelong years it has been around, beer has been associated with leisure and relaxation. Of late, it has become more than just a beverage. Both amateurs and aficionados prefer an uncorked chilled beer to unwind on a sweltering hot day. As the temperature rises, the breweries gear up to capitalise on this growing trend.

'Our focus is on converting lands into projects'

'Our focus is on converting lands into projects'

Rediff.com   25 Apr 2024

'There has been a huge shift. Consumer needs and requirements have changed, and differ from city to city.'

Gut Health Key To Prevent Chronic Illnesses

Gut Health Key To Prevent Chronic Illnesses

Rediff.com   24 Apr 2024

Maintaining the balance of gut microbiota is important as an imbalance, also known as dysbiosis, can cause or aggravate different diseases, including but not limited to digestive problems such as inflammatory bowel syndrome, mental health issues like anxiety and depression and menstrual problems.

Zydus gets China nod for kidney disease drug

Zydus gets China nod for kidney disease drug

Rediff.com   24 Apr 2024

Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its oral drug Desidustat used in treating anaemia in chronic kidney disease (CKD) patients had been accepted by the National Medical Products Administration of China (NMPA). In 2020, CMS International Development and Management Ltd, a wholly-owned subsidiary of China Medical System Holdings Ltd obtained an exclusive license for the product from Zydus. CKD involves a gradual loss of functioning of kidneys and eventually leads to kidney failure.